Robert J. Greenberg is Chairman at SECOND SIGHT MEDICAL PRODUCTS INC (EYES). They have made 5 open-market trades across 2 companies since 2015, most recently 2017-06-05.
CIK 0001625594
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PLSE | SELL | 2017-05-10 | 2017-05-10 | $21.12 | $1.1M | +30.5% | +46.2% | +14.1% |
| EYES | SELL | 2016-12-01 | 2016-12-02 | $1.96 | $4K | -2.1% | +3.7% | -19.5% |
| EYES | SELL | 2016-06-02 | 2016-06-06 | $4.10 | $35K | -0.8% | -11.3% | -8.9% |
| EYES | SELL · 10b5-1 | 2016-04-18 | 2016-04-20 | $5.27 | $43K | -10.4% | -29.3% | -22.8% |
| EYES | SELL | 2015-12-07 | 2015-12-09 | $5.30 | $95K | -33.1% | -22.1% | -5.5% |
| EYES | SELL · 10b5-1 | 2015-06-02 | 2015-06-04 | $14.04 | $2.1M | -33.1% | -0.9% | -0.9% |
| EYES | SELL | 2015-03-20 | 2015-03-24 | $13.28 | $1.3M | -33.1% | -0.9% | -0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.